应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09989 海普瑞
休市中 04-30 16:08:11
4.840
+0.030
+0.62%
最高
4.890
最低
4.820
成交量
48.35万
今开
4.820
昨收
4.810
日振幅
1.46%
总市值
71.00亿
流通市值
10.65亿
总股本
14.67亿
成交额
234.68万
换手率
0.22%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每周股票复盘:海普瑞(002399)Q1净利增19.79%
证券之星 · 08:18
每周股票复盘:海普瑞(002399)Q1净利增19.79%
海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显
证券之星 · 05-01 06:41
海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显
海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%
证券之星 · 04-29
海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%
海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力
公告速递 · 04-29
海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力
海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%
智通财经 · 04-29
海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%
海普瑞(002399)披露2025年度业绩说明会安排,4月15日股价上涨0.88%
证券之星 · 04-15
海普瑞(002399)披露2025年度业绩说明会安排,4月15日股价上涨0.88%
股市必读:海普瑞(002399)4月8日董秘有最新回复
证券之星 · 04-09
股市必读:海普瑞(002399)4月8日董秘有最新回复
海普瑞:公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现
证券之星 · 04-03
海普瑞:公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现
海普瑞3月无新增发行或股份变动
公告速递 · 04-02
海普瑞3月无新增发行或股份变动
海普瑞将于2026年7月22日派发末期股息每股0.15元
公告速递 · 03-31
海普瑞将于2026年7月22日派发末期股息每股0.15元
海普瑞将于2026年07月22日派发末期股息每股0.15元
公告速递 · 03-31
海普瑞将于2026年07月22日派发末期股息每股0.15元
商业化与平台能力加速升级 解锁海普瑞长期增长密码
中金财经 · 03-31
商业化与平台能力加速升级 解锁海普瑞长期增长密码
海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%
智通财经 · 03-30
海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%
海普瑞将于2026年7月22日派发末期股息每股0.15元
公告速递 · 03-30
海普瑞将于2026年7月22日派发末期股息每股0.15元
股市必读:海普瑞(002399)3月23日收盘跌6.09%,主力净流入138.86万元
证券之星 · 03-24
股市必读:海普瑞(002399)3月23日收盘跌6.09%,主力净流入138.86万元
国内首家超高纯管阀件企业完成新一轮融资
爱集微 · 03-09
国内首家超高纯管阀件企业完成新一轮融资
海普瑞03月04日获主力加仓89.9万元
市场透视 · 03-04
海普瑞03月04日获主力加仓89.9万元
海普瑞(09989)更新2026年2月股份变动月报表,股本维持稳定
公告速递 · 03-02
海普瑞(09989)更新2026年2月股份变动月报表,股本维持稳定
海普瑞02月26日主力净流出64.9万元 散户资金买入
市场透视 · 02-26
海普瑞02月26日主力净流出64.9万元 散户资金买入
海普瑞02月12日主力净流出44.5万元 散户资金买入
市场透视 · 02-12
海普瑞02月12日主力净流出44.5万元 散户资金买入
加载更多
公司概况
公司名称:
海普瑞
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市海普瑞药业集团股份有限公司是一家主要从事肝素产业链、生物大分子合同开发和生产组织(CDMO)和创新药物的投资、开发及商业化的中国公司。该公司运营四个分部。药品制剂分部生产和销售依诺肝素钠注射液等。原料药物分部生产和销售标准肝素活性药物和依诺肝素活性药物等。CDMO分部提供药物的中间体和原料药工艺研发服务,包括工艺研究、优化、分析检测、制剂研究等。其他分部从事其他产品业务,如胰酶、肠衣等。该公司在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.84,"timestamp":1777536491532,"preClose":4.81,"halted":0,"volume":483500,"delay":0,"changeRate":0.006237006237006289,"floatShares":220094500,"shares":1467000000,"eps":0.2382,"marketStatus":"休市中","change":0.03,"latestTime":"04-30 16:08:11","open":4.82,"high":4.89,"low":4.82,"amount":2346785,"amplitude":0.014553,"askPrice":4.87,"askSize":11000,"bidPrice":4.84,"bidSize":19500,"shortable":0,"etf":0,"ttmEps":0.264,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1594137600000,"exchange":"SEHK","adjPreClose":4.81,"dividendRate":0.056157,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":1.6586620932502667,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":10.87,"timestamp":1777532400000,"preClose":10.77,"halted":0,"volume":4494600,"delay":0,"premium":"-61.17"}},"requestUrl":"/m/hq/s/09989","defaultTab":"news","newsList":[{"id":"2632086476","title":"每周股票复盘:海普瑞(002399)Q1净利增19.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632086476","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632086476?lang=zh_cn&edition=full","pubTime":"2026-05-03 08:18","pubTimestamp":1777767495,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,海普瑞报收于10.87元,较上周的10.93元下跌0.55%。本周,海普瑞4月30日盘中最高价报11.04元。本周关注点业绩披露要点:海普瑞2026年一季报显示归母净利润1.88亿元,同比上升19.79%。业绩披露要点海普瑞2026年一季报显示,一季度公司主营收入13.31亿元,同比下降4.55%;归母净利润1.88亿元,同比上升19.79%;扣非净利润7149.39万元,同比下降62.15%;负债率28.12%,投资收益3033.14万元,财务费用1.28亿元,毛利率34.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300002052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1191","BK0188","09989","002399","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660132","title":"海普瑞(002399)2026年一季报简析:净利润同比增长19.79%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660132?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:41","pubTimestamp":1777588863,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期海普瑞发布2026年一季报。截至本报告期末,公司营业总收入13.31亿元,同比下降4.55%,归母净利润1.88亿元,同比上升19.79%。本报告期海普瑞三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达162.25%。去年的净利率为6.25%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631543515","title":"海普瑞(002399)披露2026年第一季度报告,4月29日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631543515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631543515?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:24","pubTimestamp":1777472683,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,海普瑞报收于10.77元,较前一交易日下跌0.09%,最新总市值为158.03亿元。该股当日开盘10.82元,最高10.94元,最低10.72元,成交额达4604.83万元,换手率为0.34%。近日,深圳市海普瑞药业集团股份有限公司召开第六届董事会第二十一次会议,审议通过《2026年第一季度报告》《2026年第一季度业绩公告》(H股)及《2025年度环境、社会和管治报告》。会议应参与表决董事7人,实际参与表决7人,表决结果均为7票同意、0票反对、0票弃权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900069206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002399","09989","BK1191","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195252676","title":"海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力","url":"https://stock-news.laohu8.com/highlight/detail?id=1195252676","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195252676?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:55","pubTimestamp":1777456530,"startTime":"0","endTime":"0","summary":"2025年度,海普瑞在主营肝素制剂与CDMO两大板块的协同带动下维持营收增长,实现营业收入54.38亿元人民币,同比上升3.4%。不过,受成本以及上年一次性收益基数等因素影响,年内盈利出现显著回落,归属于公司股东的净利润为3.49亿元人民币,相较2024年的6.47亿元人民币下降46%,反映出公司在成本端与市场环境中面临一定压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海普瑞2025年营收稳增至54.38亿元 肝素与CDMO双主业协同发力","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631950795","title":"海普瑞(09989)一季度归母净利润1.88亿元 同比增长19.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631950795","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631950795?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:41","pubTimestamp":1777455711,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布2026年第一季度业绩,营业收入13.31亿元,同比减少4.55%;归属于上市公司股东的净利润1.88亿元,同比增长19.79%;基本每股收益0.1278元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627423356","title":"海普瑞(002399)披露2025年度业绩说明会安排,4月15日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627423356","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627423356?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:29","pubTimestamp":1776263350,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘,海普瑞报收于11.44元,较前一交易日上涨0.88%,最新总市值为167.86亿元。该股当日开盘11.46元,最高11.55元,最低11.22元,成交额达5034.21万元,换手率为0.35%。近日,深圳市海普瑞药业集团股份有限公司发布《关于举办2025年度业绩说明会的公告》。公告显示,公司将于2026年4月20日15:00-16:30通过“价值在线”平台举行2025年度业绩说明会,以网络文字互动方式与投资者交流。说明会结束后,可通过平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","09989","BK0188","BK1191","BK0239","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626264919","title":"股市必读:海普瑞(002399)4月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2626264919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626264919?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:14","pubTimestamp":1775668453,"startTime":"0","endTime":"0","summary":"截至2026年4月8日收盘,海普瑞报收于11.68元,上涨2.55%,换手率0.53%,成交量6.67万手,成交额7731.46万元。董秘最新回复投资者: 董秘你好,贵公司A股25年年报显示:原料药的全年毛利率为15.72%,25年半年报显示:原料药的毛利率为23.82%,原料药毛利率呈明显下降趋势。当日关注点来自交易信息汇总:4月8日主力资金净流入742.52万元,呈现主动买入态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0188","002399","BK0239","09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624658540","title":"海普瑞:公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2624658540","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624658540?lang=zh_cn&edition=full","pubTime":"2026-04-03 15:00","pubTimestamp":1775199644,"startTime":"0","endTime":"0","summary":"证券之星消息,海普瑞04月02日在投资者关系平台上答复投资者关心的问题。海普瑞回复:您好,公司2025年度归母净利润同比下降,主要是2024年同期存在大额一次性投资收益的正向影响,对本报告期归母净利润同比影响较大。投资收益方面,公司对于Kymab、君圣泰等相关投资均取得了较好的收益表现,未来公司将继续坚持理性分析、有效配置、前瞻规划的投资原则。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300023601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002399","BK0239","BK1191","BK0070","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104035074","title":"海普瑞3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1104035074","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104035074?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:51","pubTimestamp":1775119870,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司于2026年4月2日公布,截至2026年3月31日止的3月股份变动月报表。报告显示,公司当月股本结构未发生变动,公开发行的A股数量为1,247,201,704股,H股数量为220,094,500股,合计1,467,296,204股,面值均为每股人民币1元。\n根据月报披露,3月期间公司未进行新增发行、购回、注销或库藏股操作,也无任何股份期权或股权激励计划行使、失效等变动。截至本月末,海普瑞的已发行股份总数保持不变,股本结构维持稳定。\n公司同时确认,已遵守所有适用的香港联交所《上市规则》及相关法律规定。该公告由联席公司秘书钱风奇签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139745407","title":"海普瑞将于2026年7月22日派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139745407","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139745407?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:11","pubTimestamp":1774966316,"startTime":"0","endTime":"0","summary":"海普瑞(09989)\n海普瑞于2026年3月30日公告,董事会建议派发截至2025年12月31日止年度的末期股息,每10股派发人民币1.45元(折合每股约人民币0.15元,四舍五入保留两位小数),并将于2026年5月22日召开股东大会审议批准。\n根据公告,股息计划于2026年7月22日派发。该股息的除净日为2026年5月27日,股东凭2026年5月28日16:30前递交的股份过户文件可享有本次股息。公司将于2026年5月29日至2026年6月2日暂停办理过户登记手续,股东记录日期为同年6月2日。港币派息金额及相关汇率将另行公布,代扣所得税信息亦有待后续披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194675150","title":"海普瑞将于2026年07月22日派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194675150","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194675150?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:11","pubTimestamp":1774966273,"startTime":"0","endTime":"0","summary":"海普瑞(09989)3月31日发布澄清公告,董事会建议派发截至2025年12月31日止年度的末期股息,每10股人民币1.45元(含税),折合每股人民币0.15元,派息方案尚待2026年5月22日举行的2025年度股东周年大会审议通过。公告显示,该末期股息将于不迟于2026年7月22日派发予2026年6月2日名列该公司H股股东名册的H股股东。\n根据公告,为符合派息资格,该公司H股股东名册将于2026年5月29日至2026年6月2日(包括首尾两日)期间暂停办理过户手续,所有办理过户的文件须于2026年5月28日16时30分前送达香港H股证券登记处。除上述事项外,此前公告所载全部其他资料保持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623794773","title":"商业化与平台能力加速升级 解锁海普瑞长期增长密码","url":"https://stock-news.laohu8.com/highlight/detail?id=2623794773","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623794773?lang=zh_cn&edition=full","pubTime":"2026-03-31 10:30","pubTimestamp":1774924201,"startTime":"0","endTime":"0","summary":"业绩增长的同时,海普瑞正持续升级工业化平台能力与全球商业化能力,以期实现公司长期高质量发展。报告期内,公司核心业务肝素制剂表现增长亮眼,依诺肝素钠制剂销量实现逾两成增长,全球收入两位数增长。另外,平台能力与智能制造建设也成为海普瑞未来高质量发展的关键因素,在市场看来,医药企业的智造能力是其全球竞争力的核心载体,并决定自身质量高度、成本优势与市场边界。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/31/20260331593458.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/31/20260331593458.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260331/32115066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","002399","BK0070","BK0239","BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623349539","title":"海普瑞(09989)发布年度业绩 股东应占溢利3.49亿元 同比减少45.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623349539","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623349539?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:24","pubTimestamp":1774880694,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海普瑞(09989)发布2025年度业绩,收入54.38亿元(人民币,下同),同比增长3.41%;母公司拥有人应占溢利3.49亿元,同比减少45.96%;每股基本盈利0.24元,拟派末期现金股息每十股公司普通股1.45元(含税)。公告称,销售产品生产及销售的收入增加,主要由于报告期内药物制剂销量大幅增长所致。 毛利率的降低乃主要由于销售成本包含了存货跌价准备,由上年的人民币760万元增至人民币3650万元,及是受市场环境影响,原料药单价呈下行趋势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","09989","BK1191","002399","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171835712","title":"海普瑞将于2026年7月22日派发末期股息每股0.15元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171835712","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171835712?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:46","pubTimestamp":1774878389,"startTime":"0","endTime":"0","summary":"海普瑞(09989)于3月30日公布,董事会宣布截至2025年12月31日止年度的末期股息,派息安排为每10股1.45人民币。若经股东于2026年5月22日批准后,除净日为2026年5月25日,股东需于2026年5月26日16时30分前递交股份过户文件,于2026年5月27日至5月29日暂停办理股份过户登记,并于2026年5月29日为记录日期。股息预计将于2026年7月22日派发。公司预设派发货币为港元,具体金额及汇率有待公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621828900","title":"股市必读:海普瑞(002399)3月23日收盘跌6.09%,主力净流入138.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621828900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621828900?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:33","pubTimestamp":1774297990,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,海普瑞报收于10.33元,下跌6.09%,换手率0.51%,成交量6.34万手,成交额6685.07万元。来自资金流向:3月23日主力资金净流入138.86万元,与前10个交易日主力资金累计净流出形成反差。交易信息汇总股价提醒3月23日海普瑞收盘报10.33元,跌6.09%,当日成交633.61万元。根据收盘数据统计,该股已连续3日下跌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","09989","BK1191","BK0188","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618398079","title":"国内首家超高纯管阀件企业完成新一轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2618398079","media":"爱集微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618398079?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:47","pubTimestamp":1773064077,"startTime":"0","endTime":"0","summary":"近日,海普瑞(常州)洁净系统科技有限公司宣布完成B++轮投资。海普瑞成立于2022年,是国内首家专注于半导体级 PVDF-UHP、PFA-UHP超高纯管材、管件、阀门及测量控制仪表研发制造的企业,也是国内少数能打破欧美日韩在超高纯液路系统垄断的企业。海普瑞先后荣获国家级高新技术企业、专精特新企业、潜在独角兽企业等荣誉称号。2025年6月,海普瑞完成B+轮融资,此轮融资得到京东方、合肥产投、超越摩尔及某一体化存储器制造公司的大力支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309215039a45bdb3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309215039a45bdb3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616558874","title":"海普瑞03月04日获主力加仓89.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558874","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616558874?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:16","pubTimestamp":1772612169,"startTime":"0","endTime":"0","summary":"03月04日, 海普瑞股价涨0.39%,报收5.17元,成交金额930.9万元,换手率0.82%,振幅1.94%,量比1.56。海普瑞今日主力资金净流入89.9万元,上一交易日主力净流入45.1万元。|03月04日主力加仓幅度排名||#|股票简称|主力净额占比|#|亨泰|3.78%|#|山东墨龙|1.92%|#|喜相逢集团|1.88%|#|...|...|#89|海普瑞|0.08%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304162237a6a141eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304162237a6a141eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145540892","title":"海普瑞(09989)更新2026年2月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1145540892","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145540892?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:41","pubTimestamp":1772440913,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司(09989)于2026年3月3日发布截至2026年2月28日的股份变动月报表。报告期内,公司股本结构未发生新增发行或回购注销等变化,股本继续保持稳定。\n根据公告,公司于香港联交所上市的H股维持220,094,500股;于深圳证券交易所上市的A股则维持1,247,201,704股。截至2026年2月28日,注册股本总额为人民币1,467,296,204元。公司在报告期内无任何期权、认股权证或可换股票据的发行、行使或注销情形。\n公告显示,公司确认遵守香港联合交易所有限公司《上市规则》及相关法律法规。上述月报表由联席公司秘书钱风奇签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614077976","title":"海普瑞02月26日主力净流出64.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614077976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614077976?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093728,"startTime":"0","endTime":"0","summary":"02月26日, 海普瑞股价跌0.95%,报收5.20元,成交金额511.0万元,换手率0.45%,振幅2.29%,量比2.43。海普瑞今日主力资金净流出64.9万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.07%,主力资金累计净流出36.9万元;近20日主力资金累计净流出230.6万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161657a4caa0e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161657a4caa0e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611906307","title":"海普瑞02月12日主力净流出44.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2611906307","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611906307?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:15","pubTimestamp":1770884138,"startTime":"0","endTime":"0","summary":"02月12日, 海普瑞股价跌0.73%,报收5.46元,成交金额303.4万元,换手率0.25%,振幅2.18%,量比0.76。海普瑞今日主力资金净流出44.5万元,上一交易日主力净流入33.9万元。该股近5个交易日下跌1.08%,主力资金累计净流出166.9万元;近20日主力资金累计净流出121.4万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161821a6f27a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212161821a6f27a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","09989"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":-0.0041},{"period":"3month","weight":-0.1232},{"period":"6month","weight":-0.1004},{"period":"1year","weight":0.1549},{"period":"ytd","weight":-0.071}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家主要从事肝素产业链、生物大分子合同开发和生产组织(CDMO)和创新药物的投资、开发及商业化的中国公司。该公司运营四个分部。药品制剂分部生产和销售依诺肝素钠注射液等。原料药物分部生产和销售标准肝素活性药物和依诺肝素活性药物等。CDMO分部提供药物的中间体和原料药工艺研发服务,包括工艺研究、优化、分析检测、制剂研究等。其他分部从事其他产品业务,如胰酶、肠衣等。该公司在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.055051},{"month":2,"riseRate":0.5,"avgChangeRate":0.044249},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.06634},{"month":4,"riseRate":0.5,"avgChangeRate":0.02649},{"month":5,"riseRate":0.8,"avgChangeRate":0.036786},{"month":6,"riseRate":0.4,"avgChangeRate":0.016261},{"month":7,"riseRate":0.4,"avgChangeRate":0.018989},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.02601},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.052556},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.027986},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.010242},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.022555}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}